Early Immunological Studies Show Universally Effective Antibodies Against SARS-CoV-2 in Recovered HumansNews
The first round of results from an immunological study of 149 people who have recovered from COVID-19 show that although the amount of antibodies they generated varies widely, most individuals had generated at least some that were intrinsically capable of neutralizing the SARS-CoV-2 virus.READ MORE
Rat Study Suggests "Good Bacteria" Could Relieve Autism-like Symptoms in PregnancyNews
Giving beneficial bacteria to stressed mothers during the equivalent of the third trimester of pregnancy prevents an autism-like disorder in their offspring, according to a new animal study by University of Colorado Boulder researchers.
Complex Role of Immune Molecule in Huntington’s DiseaseNews
Abnormally high levels of an immune-system molecule, interleukin-6 (IL-6), prior to Huntington’s disease symptoms suggested it led to disease progression. However, Huntington’s model mice bred to lack IL-6 showed exacerbated symptoms compared to mice that still had it, indicating a complex relationship.
Trial Investigates Remdesivir–Baricitinib Combo as COVID-19 TreatmentNews
Following on from remdesivir’s promising results from previous studies, a new trial is now investigating remdesivir in combination with baricitinib or placebo as a treatment for COVID-19, in a double-blind, randomized trial.READ MORE
IVT and Solvo have collaborated to leverage IVT’s strength in the marketplace and Solvo’s Membrane Transporter products.READ MORE
OncoTherapy and BioWa will apply their technologies for the enhancement of antibody-dependent cellular cytotoxicity.READ MORE
Monogram will test formalin-fixed, paraffin-embedded (FFPE) tumor samples from patients with colorectal cancer.READ MORE
Companies combine their technologies to enable advances in genomic discovery and delivery of healthcare diagnostics.READ MORE
Systat and Equbits embark on partnership to bring automated SVM modeling to the data mining community.READ MORE
Boehringer will use Syntonix' SynFusion™ and Transceptor™ technologies to optimize peptides for inhalation.READ MORE
The finding adds to mounting evidence of dopamine's link to psychiatric and neurological disorders.READ MORE
BioWa expects to develop and commercialize anti-FGF8 antibody.READ MORE